Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Nurix Therapeutics Insider Sold Shares Worth $528,528, According to a Recent SEC Filing

Nurix Therapeutics Insider Sold Shares Worth $528,528, According to a Recent SEC Filing

MT newswireMT newswire2026/10/14 20:19
04:19 PM EDT, 10/14/2026 (MT Newswires) -- Julia P Gregory, Director, on October 14, 2026, sold 22,583 shares in Nurix Therapeutics (NRIX) for $528,528. Following the Form 4 filing with the SEC, Gregory has control over a total of 10,750 common shares of the company, with 10,750 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1549595/000122667526000006/xslF345X05/wk-form4_1792008695.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

JPMorgan Chief Global Strategist: Tech stock trading has entered a phase of volatility and uncertainty; investors should diversify their AI holdings

David Kelly, Chief Global Strategist at JPMorgan Asset Management, stated that as the artificial intelligence (AI) industry shows signs of entering a new phase characterized by increased volatility and rising technological uncertainty, investors should diversify their AI-related holdings.

智通财经•2026/11/17 04:11
JPMorgan Chief Global Strategist: Tech stock trading has entered a phase of volatility and uncertainty; investors should diversify their AI holdings